Literature DB >> 23725334

Inappropriate use of nonsteroidal anti-inflammatory drugs and other drugs in chronic kidney disease patients without renal replacement therapy.

Ugur Bilge1, Garip Sahin, Ilhami Unluoglu, Muhterem Ipek, Murat Durdu, Ahmet Keskin.   

Abstract

OBJECTIVE: The main goal of chronic kidney disease (CKD) treatment is the prevention of progression of the disease and complications. Inappropriate drug use in patients with CKD is an important issue, which may cause adverse effects on patients and progression of chronic renal failure. The aim of this study is to find the rate of inappropriate drug use among CKD patients.
METHODS: The subjects of this study were selected from the patients with a CKD history of minimum one year, who did not receive renal replacement therapy. Patients were asked to provide a digital record of the drugs they used over the last one year. Individually, for each patient, the drugs that may be contraindicative and that require dose adjustment were identified based on glomerular filtration rate (GFR).
RESULTS: This study includes a total of 185 participants - 97 female (52.4%) and 88 male (47.6%) patients. The average age of patients was 60.50 ± 14.56. It was shown that 149 patients (80.5%) were using inappropriate drugs. Seventy (47.0%) were using one, 79 (53.0%) two, 30 (20/1%) three, and 9 (6.4%) four inappropriate drugs. Of CKD patients, 44.3% were aged 65 or over; and in this age group, inappropriate drug use was more frequent compared to the population below 65 (86.6% vs. 75.7%). The drugs used inappropriately were, respectively, nonsteroidal anti-inflammatory drugs (65.8%), quinolone antibiotics (39.0%), ACE inhibitors (26.9%). DISCUSSION: Health professionals are required to consider renal functions of all patients, mainly those aged over 65, when administering a treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23725334     DOI: 10.3109/0886022X.2013.801272

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  9 in total

1.  Analysis of the association between emergency dialysis start in patients with end-stage kidney disease and non-steroidal anti-inflammatory drugs, proton-pump inhibitors, and iodinated contrast agents.

Authors:  Aurélie Pétureau; Maxime Raffray; Elisabeth Polard; Cécile Couchoud; Cécile Vigneau; Sahar Bayat
Journal:  J Nephrol       Date:  2021-04-20       Impact factor: 3.902

2.  Prescription of high-risk medications among patients with chronic kidney disease: a cross-sectional study from the Washington, Wyoming, Alaska, Montana and Idaho region Practice and Research Network.

Authors:  Janelle Guirguis-Blake; Gina A Keppel; John Holmes; Rex W Force; William Kriegsman; Laura-Mae Baldwin
Journal:  Fam Pract       Date:  2018-09-18       Impact factor: 2.267

3.  Can NSAIDs Be Used Safely for Analgesia in Patients with CKD?: COMMENTARY.

Authors:  Megan L Baker; Mark A Perazella
Journal:  Kidney360       Date:  2020-09-23

4.  Use of renal risk drugs in patients with renal impairment.

Authors:  Hilde Holm; Kirsti Bjerke; Lone Holst; Liv Mathiesen
Journal:  Int J Clin Pharm       Date:  2015-08-18

5.  Primary Care Prescriptions of Potentially Nephrotoxic Medications in Children with CKD.

Authors:  Claire E Lefebvre; Kristian B Filion; Pauline Reynier; Robert W Platt; Michael Zappitelli
Journal:  Clin J Am Soc Nephrol       Date:  2019-12-12       Impact factor: 8.237

6.  Inappropriateness of medication prescriptions about chronic kidney disease patients without dialysis therapy in a Chinese tertiary teaching hospital.

Authors:  Ping Yang; Na Chen; Rong-Rong Wang; Lu Li; Sai-Ping Jiang
Journal:  Ther Clin Risk Manag       Date:  2016-10-12       Impact factor: 2.423

7.  Use of renal risk drugs in a nation-wide Polish older adult population: an analysis of PolSenior database.

Authors:  Ewa Deskur-Śmielecka; Jerzy Chudek; Agnieszka Neumann-Podczaska; Małgorzata Mossakowska; Barbara Wizner; Katarzyna Wieczorowska-Tobis
Journal:  BMC Geriatr       Date:  2019-03-05       Impact factor: 3.921

8.  Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study.

Authors:  Samar Abd ElHafeez; Reem Hegazy; Yasmine Naga; Iman Wahdan; Sunny Sallam
Journal:  J Egypt Public Health Assoc       Date:  2019-01-30

9.  A systematically collated library of prescribing safety indicators for people with chronic kidney disease.

Authors:  Fiona Smith; Samantha Hayward; Barnaby Hole; George Kimpton; Christine Sluman; Penny Whiting; Fergus Caskey
Journal:  BMC Nephrol       Date:  2020-11-18       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.